DermView

Panelists discuss how advancements in topical PDE4 inhibitors, particularly roflumilast and crisaborole, are reshaping the management of atopic dermatitis by offering new nonsteroidal options with distinct mechanisms of action and safety profiles.

Karan Lal, DO, and Helen T Shin, MD, discuss the challenges, treatment options, research needs, and impact of pediatric plaque psoriasis, highlighting early diagnosis, the potential of PDE4 inhibitors, and the importance of addressing long-term safety and psychosocial effects.

Elizabeth Kiracofe, MD, and Jenny Murase, MD, explore systemic treatments for atopic dermatitis in the context of reproductive health, for patients during pregnancy, pre-pregnancy, postpartum, and breastfeeding.

Experts in dermatology provide a comprehensive year in review regarding the management of plaque psoriasis, highlighting key therapeutic approvals from 2023. The discussion will highlight pivotal clinical studies supporting these approvals and our discussion will then pivot to have a special focus on addressing the unique challenges faced by treating patients with skin of color and treatment access barriers.

Experts in dermatology delve into the unique characteristics of plaque psoriasis and its impact on patients' quality of life. They further explore how dermatological providers can optimize care by transitioning patients to more effective and innovative systemic options to manage this condition, ultimately advancing both patient outcomes and overall well-being.

Experts in dermatology explore how to facilitate and engage patients living with vitiligo in a constructive conversation about the use of topical therapy for this condition emphasizing the importance of appropriate follow-up and monitoring practices to ensure treatment success.

During this discussion, expert dermatologists focus on the role of nonsteroidal topicals in the treatment of plaque psoriasis. They highlight the safety and efficacy of these treatments and their role in the management of patients with plaque psoriasis.

Experts discuss their clinical experience using topical therapies to treat atopic dermatitis (AD), highlighting recent developments in the treatment landscape and prospective approaches for improved outcomes.

In this upcoming video program, Lauren Miller, PA-C will lead a conversation about the management of plaque psoriasis; focusing on data relating to emerging efficacy and safety outcomes highlighting key disease clearance endpoints related to the practical and clinical considerations of this condition.

Dermatology experts discuss non-steroidal, topical treatment options for patients with plaque psoriasis.

Experts in dermatology discuss prevalence, communication with patients, and exciting new treatments in vitiligo.

Psoriasis experts discuss updates with IL-17 inhibitors and how they have changed the treatment landscape for plaque psoriasis.

Psoriasis experts discuss updates with TNF inhibitors and how they have changed the treatment landscape for psoriatic disease.

Expert rheumatologist and dermatologist discuss biosimilars and impact of biosimilars on the field of rheumatology and dermatology.

Experts in dermatology discuss presentation and treatment of atopic dermatitis (AD) in patients with skin of color SOC). Through a discussion of patient cases, they present rationale for where and why they would use recently approved AD treatments in pediatric population.

Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.

James Q. Del Rosso, DO, and Neal Bhatia, MD, discuss the role of topical and oral JAK inhibitors in inflammatory disease management.

Linda Stein Gold, MD, and Matthew Zirwas, MD, provide a discussion on the role of JAK inhibitors in inflammatory diseases.

Expert dermatologists provide an overview of vitiligo while reviewing presentation, diagnosis, and the goals of therapy related to current and future therapies.

In this expert series, Adelaide Hebert, MD, chief of pediatric dermatology at the McGovern Medical School at UTHealth Houston, Texas, provides an overview of eczema while discussing environmental factors of the skin condition, the role of emollients and moisturizers, and how ceramide containing creams can help.